Sunnyvale, CA / ACCESSWIRE / December 10, 2014 / Arrayit Corporation (ARYC) announces that it has signed a Cooperative Research and Development Agreement (CRADA) with the United States Department of Agriculture (USDA) entitled "Rapid and Cost Effective Detection Technologies for Noroviruses and other Foodborne Pathogens." Under the terms of the agreement, Arrayit and the USDA Agricultural Research Service (USDA ARS) will develop and validate a rapid, portable, cost-effective and high-throughput detection system for the surveillance of multiple bacterial and viral foodborne pathogens including hepatitis, E. coli, Salmonella, Listeria, Campylobacter and Norovirus. The expected outcome is a commercial test that will be widely deployed throughout the lifecycle of food production and distribution to ensure that our food supply is safe for consumption.
The USDA seeks to expand economic opportunity through innovation to better nourish Americans by working cooperatively with the private sector. The USDA's $146 billion 2014 budget includes $123 billion of mandatory programs and $23 billion of discretionary spending for programs including food safety.
Arrayit and the USDA will utilize Arrayit's patented and proprietary DNA microarray platform and USDA's patent pending method to detect DNA sequences present in potentially life-threatening foodborne pathogens that periodically contaminate fruits, vegetables, meats, poultry and dairy products. According to the Centers for Disease Control and Prevention (CDC), foodborne illnesses afflict 1 in 6 Americans annually resulting in 128,000 hospitalizations, 3,000 deaths and more than $150 billion in economic losses.
Arrayit CEO Rene Schena states, "We are pleased to cooperate with the USDA to develop and commercialize rapid and cost-effective food safety surveillance based on Arrayit's widely used microarray technology and USDA's patent pending method. Deploying affordable, high throughput testing throughout food production and distribution will improve the quality of foods brought to market and further ensure public health and safety."
About Arrayit Corporation
Arrayit utilizes its patented and proprietary microarray platform to lead and empower the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
- Powerful Science for Life(TM)
Visit www.arrayit.com or more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2013 and in Form 10-Q for the quarterly period ended September 30, 2014.
Investor Relations
Arrayit Corporation
408.744.1331
[email protected]
SOURCE: Arrayit Corporation